Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Share-based Compensation (2020 - 2023)

Terns Pharmaceuticals' Share-based Compensation history spans 4 years, with the latest figure at $3.3 million for Q4 2023.

  • For Q4 2023, Share-based Compensation rose 22.14% year-over-year to $3.3 million; the TTM value through Dec 2023 reached $25.5 million, up 137.15%, while the annual FY2025 figure was $13.4 million, 14.26% down from the prior year.
  • Share-based Compensation reached $3.3 million in Q4 2023 per TERN's latest filing, down from $14.1 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $14.1 million in Q3 2023 to a low of $190000.0 in Q2 2020.
  • Average Share-based Compensation over 4 years is $2.9 million, with a median of $2.6 million recorded in 2021.
  • Peak YoY movement for Share-based Compensation: surged 904.74% in 2021, then increased 5.37% in 2022.
  • A 4-year view of Share-based Compensation shows it stood at $786000.0 in 2020, then soared by 224.43% to $2.6 million in 2021, then rose by 5.37% to $2.7 million in 2022, then rose by 22.14% to $3.3 million in 2023.
  • Per Business Quant, the three most recent readings for TERN's Share-based Compensation are $3.3 million (Q4 2023), $14.1 million (Q3 2023), and $4.2 million (Q2 2023).